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ABSTRACT

Objective: In 2018, over 586,000 US citizens were reported to be addicted to
intravenous heroin. It was reported by the Centers for Disease Control (CDC) that in
2017, 70,237 people ages 25 years to over 65 years died from a drug overdose in the
United States; analogous to roughly the number of people residing in Portland, Maine.
Needle exchange programs have been found to be effective at reducing needlestick
injuries in the community, reducing associated health care costs and improving the shortterm and long-term health of people who use injection drugs (PWUID). Of all health care
providers, emergency department nurses who work in the emergency department are
most likely to provide care to PWUID and have the opportunity to provide resources and
compassionate care for individuals struggling with injection drug use, thus they are
uniquely positioned to inform PWUID of the availability and benefits of needle exchange
programs. The purpose of this study is to describe the perceptions of emergency
department nurses regarding the needle exchange program in Bangor, Maine and to see
how to increase the utilization of NEPs.
Methods: An anonymous survey to determine perceptions of needle exchange
facilities was distributed to emergency department nurses (ED) in Bangor, Maine. There
are 75 nurses in total who work in the ED in one hospital in Bangor, ME and out of these
75, nine surveys (12 %) were returned. One nurse did leave their contact information to
set up an interview, however the interview was not able to take place due the inability to
get in contact with them.

Results: Of the 9 nurses surveyed, 3 (33%) were unaware of the Needle Exchange
Program in Bangor. Of the 9 nurses surveyed, only 3 (33%) believed that harm reduction
programs like NEPs reduced the rates of infectious diseases in PWUID and in the
community. Therefore, in order to make strides to increase NEP utilization, more ED
nurses should be educated on the specific needle exchange services located in the area.
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LITERATURE REVIEW

Introduction
Intravenous (IV) substance abuse is a serious public health problem in the United
States (Charms, 2017). In 2015, 586,000 U.S. citizens over twelve had a heroin use
disorder (American Addiction Centers, 2019). In 2017, 70,237 people ages 25 years to
over 65 years died from a drug overdose in the United States; analogous to roughly the
number of people residing in Portland, Maine (Sternberg, 2017). This represents a 17%
increase from the previous year, illustrating this growing nationwide epidemic
(Sternberg, 2017). In 2016, the national average of overdose deaths was 19.8 per
100,000 individuals (NCHS, 2018) According to the Centers for Disease Control (CDC),
states with the highest rates of drug overdose mortality per 100,000 individuals included
West Virginia (52), Ohio (39.1), New Hampshire (39), Pennsylvania (37.9), Kentucky
(33.5), Maryland (33.2), Massachusetts (33), Rhode Island (30.8), Delaware (30.8) and
Maine (28.7) (NCSH, 2018).
Between 2011-2014, there was a 34% increase in IV drug related overdose deaths
in Maine (Diomede, 2015). These IV drugs included heroin or injectable water-soluble
drug such as amphetamines, buprenorphine, benzodiazepines, barbiturates, cocaine, or
methamphetamine (Baciewicz, 2017). Heroin represented 25% of IV drug overdoses
(Charms, 2017). Differences in the incidence of IV drug related overdoses in Maine
varies by county. The county with the highest incidence of IV drug related overdose
deaths per 100,000 residents was Washington County with 19.7 followed by
Androscoggin County (17.7), Cumberland County (16.1), Kennebec (15.9), Somerset
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(14.2), Waldo (13.7), Lincoln (13.7), York (13.4), Penobscot (12.8), Knox (12.6),
Aroostook (9.5), Sagadahoc (8.6), Hancock (8.5), Franklin (7.7), Piscataquis (5.4), and
Oxford (5.2) (Charms, 2017; Diomede, 2015).

Consequences of IV Substance Use
IV drug abuse presents a multitude of problems for the addicted individual, their
family and friends, and the community (Moses, Woodcock, Lister, Lundahl &
Greenwald, 2018). For the individual, there are health consequences such as infection and
social consequences. These health consequences can be both short and long term. For
the community, safety may be jeopardized due to exposure to infection from dirty needles
left in public places.

Health Consequences
Health consequences of heroin use may include acute heroin toxicity, overdose,
infection with blood borne pathogens, and infection and damage to the skin and soft
tissue at the injection site. Acute heroin toxicity is a health consequence experienced by
PWUID. Symptoms of acute heroin toxicity result when heroin crosses the blood-brain
barrier. Heroin metabolizes into morphine and binds with opioid receptors in the brain to
produce a “high” (OSHA, 2018). Beyond the desired high, acute symptoms that occur
include respiratory irritation, bronchospasm, meiosis, diplopia, nausea, vomiting,
constipation, euphoria, dizziness, sleepiness, coma, respiratory depression, pulmonary
edema and death (OSHA, 2018). Additionally, severe itching, warm flushed skin, runny
nose, watery eyes, sensation of heaviness in limbs, muddled thinking and dilated pupils
can also occur (American Addiction Centers, 2019). These acute symptoms can interfere
2

with the individual’s ability to think and act clearly. Hence, there is the potential that this
inability to think and act clearly may interfere with performance of daily work tasks and
family responsibilities (Daley, 2013).
Heroin is rapidly absorbed and effects are experienced in under sixty seconds
beginning with euphoria. Heroin users inject around two to four times a day since the
euphoric effects only last for three to five hours (OSHA, 2018). Because of this short
lived “high”, PWUID cycle between feeling the effects of euphoria and then feeling the
often physically tortuous symptoms of withdrawal (OSHA, 2018).
A potential acute lethal consequence of heroin use is an overdose. Heroin
specifically targets the central and peripheral nervous system but may affect all body
systems. Heroin, effects the central nervous system as it rapidly crosses the blood-brain
barrier and is metabolized into morphine. Morphine binds to opioid receptors in the brain
and spinal cord. When morphine binds to these opioid receptors two physiologic effects
occur; the sensation of pain is blocked and increased amounts of dopamine are released.
Dopamine is a neurotransmitter that causes euphoria (Drugbank, 2019). Respiratory
depression is the underlying cause of heroin overdose deaths. Heroin effects the
respiratory center of the brain by causing respiratory depression and death (World Health
Organization, 2019).
PWUID are also at increased risk of acute infection from blood borne pathogens
such as hepatitis B, C, or D and HIV resulting from methods of injecting these
substances. Equipment to inject IV drugs includes syringes, cookers, cotton, and bands.
Syringes are the means of injection. Cookers may be spoons or bottle caps in which the
powdered heroin is placed, heated, and melted into a liquid that can be drawn up in a
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syringe for injection. Cotton serves as a filter to strain impure solids that did not melt
during the heating or “cooking” process. The band is wrapped around the extremity in
which the person will inject the heroin. It can be a rubber band, shoelace or any item that
can act as a tourniquet (American Addiction Center, 2018).
PWUID may use dirty needles or share needles which is a major risk factor for
blood borne infections (Fox, Oliver, & Ellis, 2013). PWUID use hypodermic needles that
are often times dirty, meaning used by another person or previously used by themselves.
When surveyed, 28% of PWUID reported actively share syringes with other users thus
spreading serious diseases like HIV and hepatitis B and C. Twenty-one percent of IV
drug users are hepatitis B positive and 50% are hepatitis C (HCV) positive (Fox, Oliver,
& Ellis, 2013).
In order to avoid the transmission of blood borne pathogens, it is suggested that a
new syringe and injecting equipment should be used each time. Bleach has been proven
to significantly decrease transmission rates but it is not one hundred percent effective
(Abdala, 2001). For example, bleach does have the ability to kill HCV 99% of the time.
Furthermore, if the bleach used to clean the equipment is expired, its efficacy is reduced.
HCV can live in a syringe for 63 days, in water for 21 days, on surfaces for 42 days, and
on cotton filters for 24 hours. Hence, despite cleaning, many syringes have dead space
where blood stays in the syringe and serves as a reservoir for HCV. Cookers may also be
shared and serve as a primary means of transmission of HCV (Reynolds, 2016).
Hepatitis B (HBV) and Hepatitis C (HCV) are transmitted by sexual contact as
well as sharing equipment used to inject drugs. Some people who are infected with HBV
and HCV can completely recover from the disease with no long-term sequelae. The
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majority of these individuals will then have lifelong immunity to HBV and HCV. HBV
has a higher rate of full recovery than HCV. Ninety percent of all adults with HBV will
fully recover and 10% will go on to develop chronic infection. However, 75% to 85% of
those infected with HCV will develop chronic infection (CDC, 2019). Chronic infection
with HBV and/or HCV is the most common cause of liver cancer and cirrhosis
(Underferth, 2017).
PWUID are also at increased risk of skin and soft tissue infections (SSTI) when
they reuse needles. Repeatedly using the same needle leads to dulling of the bevel of the
needle which results in damage to skin, soft tissue and the vein. This damage increases
the likelihood of abscess formation (Reynolds, 2016). SSTI’s frequently lead to
hospitalization for associated complications such as of bacteremia which can lead to
sepsis, endocarditis, and osteomyelitis. These complications of SSTI’s requires
hospitalization for monitoring and treatment with intravenous antibiotics (Tookes,
Diaz, Li, Khalid, & Doblecki-Lewis, 2015). Other health conditions associated with
intravenous heroin use include thrombosed veins, pneumonia, rhabdomyolysis, acute
renal failure, irregular menses in females, intense aggression and irritability, seizures,
impaired attention, learning, memory, reaction time, impulse control and compartment
syndrome ((Fox, Oliver, & Ellis, 2013; OSHA, 2018).

Consequences of tolerance and addiction
The act of withdrawing from heroin has unique health consequences separate
from overdose, blood borne infection, and skin and soft tissue infection. In order to
understand the concept of and physiologic effects of drug withdrawal, an understanding
of tolerance and addiction is required. Both tolerance and addiction can harm the body
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but in different ways. Tolerance is defined as needing more of a certain substance to
achieve the same effect (Fox, Oliver, & Ellis, 2013). In the case of heroin, tolerance
poses a further threat to the health of the individual because in smaller concentrations
heroin would be less toxic to body systems. When increasingly higher doses of heroin
are required to achieve the desired effects, the level of toxicity to body systems increases.
Tolerance and addiction do not mean the same thing however, because a person could
develop tolerance to pain medications as a result of long-term use. For example, tolerance
would be present when a person with pain requires increased dosages to achieve the
desired effect of reduced pain. People who have a tolerance to a substance do not
necessarily experience symptoms of withdrawal from the substance. However, the need
for increased amounts of heroin to achieve the desired effect results in organ damage
because of toxicity from higher concentrations of the substance (American Addiction
Centers, 2018).
Addiction can also damage body systems but in a different way than tolerance. A
person who is addicted to a substance experiences physiologic symptom of withdrawal
when the substance is stopped because the body is no longer in a state of homeostasis.
Addiction affects the neurological pathways (Fox, Oliver, Ellis, 2013). Dopamine is a
neurotransmitter in the brain which is involved with rewarding behaviors. When someone
experiences something positive, their brain releases dopamine which prompts the person
to partake in that particular behavior again. However, heroin also has this same effect
because it causes a rush of dopamine into the brain which creates the euphoric effects. As
a consequence, the individual is prompted to continue the same behavior because of the
positive reaction they received from their brain (Drugbank.org, 2019). Heroin increases
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the amount of dopamine released to ten times the normal amount (Fox, Oliver, Ellis,
2013). When dopamine levels drop, as a result of discontinuation of heroin intake,
physiologic symptoms of withdrawal occur because the brain no longer produces the
needed amounts of dopamine because of the heroin use creating such an excess of
dopamine (Fox, Oliver, Ellis, 2013).
Heroin withdrawal typically lasts for a week with the most intense symptoms
during the first six- to twelve hours. During this period of withdrawal, the PWUID would
experience severe drug cravings which may lead to a relapse, abdominal pain, nausea,
sweating, shaking, nervousness, agitation, depression and muscle spasms (American
Addiction Centers, 2018). After the first week, there is a period of time called the PostAcute Withdrawal Stage in which some symptoms can persist from weeks to months to
even years, depending on the individual. Generally, the symptoms one experiences while
in withdrawal are not life threatening, however, some symptoms can be very severe
depending on the situation and duration of the drug use which could result in
complications that could be dangerous and life threatening and result in death.

Social consequences
Substance use can negatively impact family relationships. There is an increased
incidence of domestic violence and child abuse in families of PWUID. In fact, 80% of
child abuse cases and 75% of all foster care placements are reported to result from drug
or alcohol abuse (Keller, 2018). It has been reported that only ten percent of children
born to untreated heroin users are still with their birth mother at the age of five (Keller,
2018). Children of parents with substance use disorders are consequently more likely to
be abused or neglected, have poor behavior, have physical problems, have poor
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emotional regulation, and are more at risk to suffer from psychiatric and substance use
problems themselves (Daley, 2013). IV drug use can also place financial burden on the
family. PWUID must divert family funds or personal income to purchase these
substances (Daley, 2013). Daily cost of heroin can range from $150 to $200 a day or $54,
750 to $73,000 a year (Keller, 2018).

Societal consequences
The impact of IV drug use also has negative effects on the general population.
Societal consequences include (1) increased healthcare costs, (2) increased stress on the
legal and criminal justice system, and (3) compromised public safety. In one year, it has
been reported that more than 180 billion dollars go towards drug use health care related
costs. Twenty percent of all Medicaid dollars go towards drug related health care
(Tookes, et. al., 2015). Additionally, many PWUID are uninsured yet require higher
levels of care related to addiction. Consequently, those who have private insurance will
have higher premiums to cover the costs of healthcare for those who are uninsured.
Healthcare costs are also increased by the level of service PWUID use. PWUID are more
likely to use the emergency room and less likely to attend outpatient appointments such
as for primary visits. This increases costs especially because emergency department and
inpatient services cost more than outpatient care (French, Mcgeary, Chitwood & Mccoy,
2000). On average, PWUID are responsible for $1000 more in healthcare costs than
people who do not use injection drugs (French, et. al, 2000). One reason that PWUID
may not use primary care is because they do not have health insurance. Delay or omission
of primary care can result in an existing health issue becoming worse over time. The
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health issue can then escalate to a level that requires emergency care (French, et. Al.,
2000).
When hospitalization or emergency care is required, PWUIDs who have SSTIs
and other chronic health conditions resulting from injection drug use typically have
hospital stays longer in duration that other individuals and thus if compared with other
hospitalized patients, PWUID have an overall cost per hospitalization of $4,449 which is
far above the average (Tookes, et. al., 2015). In a study done in Florida, researchers
found that out of the 349 PWUID that were admitted to the hospital, 92% relied on
publicly funded programs or were uninsured. Other hospitals in places such as Seattle and
San Francisco also found similar results in their economic expenses where the majority of
funds were billed to Medicaid (Tookes, et. al, 2015). One solution may be to find ways to
make health insurance financially feasible to individuals who may not have insurance
(French et. al., 2000).
IV drug use also stresses the legal and criminal justice systems. PWUID are more
likely to be incarcerated which creates the need for more money to be spent on keeping
these individuals in prisons (Daley, 2013). Legal fees required by PWUID are increased
because nearly half of the federal prison population and twenty percent of the state prison
population is made up of individuals who are incarcerated on drug related charges. The
cost of incarceration is estimated to be $45 billion dollars for state prisons and $144
million for federal prisons. Both state and federal prisons are funded through taxes
(Keller, 2018).
Public safety is also at risk because the equipment used to inject the substances
can harbor dangerous bacteria and diseases which can be spread to non-drug users
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(McGuire, personal communication, October 2018). For example, if a used syringe is
encountered in a public place and someone picks it up or steps on it, the individual is at
high risk for contracting HBV, HCV, or HIV (McGuire, 2018), Community acquired
non-occupational needlestick injuries (CANSI) rates from 2001-2008 have decreased
slightly from 0.7 per 100,000 individuals to 0.5 per 100,000 individuals (Jason, 2013).
The cost of treating these CANSIs annually amounts to around 1.1 million for emergency
care and 9.8 million for the combination of emergency and follow up care (Jason, 2013).
Overall, the prevalence of CANSIs is relatively small, but these injuries are still of a
concern as they have the potential to infect community members with HBV, HCV, and
HIV (Jason, 2013).
An additional impact on society from IV drug use is the number of babies born
with neonatal abstinence syndrome (NAS) as a result of mothers using IV drugs while
pregnant (Keller, 2018). NAS is characterized by hyperactivity of the central nervous
system of the infant as well as respiratory problems, gastrointestinal problems, and
dysfunction of the autonomic nervous system (Jones, 2010). These symptoms can lead to
potentially life-threatening consequences because of the risk for seizures, feeding
difficult and diarrhea because of the hyperactive effects occurring on the gastrointestinal
tract (Jones, 2010). The incidences of babies born with NAS has tripled from 1999-2013
which further depicts the current opioid epidemic (Keller, 2018). Research is being
conducted that is looking into buprenorphine versus methadone when assisting opioid
dependent mothers on how to mitigate the negative effects of IV drug use (Jones, 2010).
A study found that when comparing these two drugs involved in MAT, that the infants of
mothers who were in the buprenorphine group needed less morphine and had shorter
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hospital stays which averaged 10 days versus 17.5, than the infants of the mothers who
received methadone during their pregnancy (Jones, 2010). Therefore, buprenorphine has
been shown to be a viable option for pregnant women who use IV drugs because it
decreases the likelihood that they will participate in risky injection behaviors in addition
to having the least impact on the neonate (Jones, 2010).
Potential Solutions to the Consequences of IV Drug Use
Overall, addiction is a complex process that affects the brain. Treatment for
addiction and the individual, social and societal consequences is multidisciplinary. Harm
Reduction methods have been reported to reduce the negative consequences. Harm
Reduction is defined as “a set of practical strategies and ideas aimed at reducing negative
consequences associated with drug use” (Harm Reduction Coalition, 2018). It
acknowledges that some ways of using drugs are safer than others, recognizes that there
is a spectrum of drug use ranging from total drug abuse to complete abstinence, focuses
on improving the quality of life of drug users. Harm reduction in no way aims to
minimize the dangers and threat that drug use poses, rather it accepts that although
unfortunate, drug abuse is prevalent in our society so instead of pretending it does not
exist, it aims at creating ways to lessen the negative consequences to both the user and
the general public (Harm Reduction Coalition, 2018).
A major goal of harm reduction is returning autonomy to the individual. Because
addiction can be described as “an element of loss of control” (Vearrier, 2018), it is
important to find methods to give back autonomy to the individual. For example, often
times, PWUID may not be ready to stop using the illicit drugs, which is when a NEP (one
method of harm reduction) can be implemented and tailored to the goals of the PWUID.
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For example, if the PWUID has a goal to decrease their risk of contracting HCV, then a
NEP may be a good fit for them. Furthermore, harm reduction programs aim at giving
control to PWUID as a way to give back their autonomy and promote beneficence
(Vearrier, 2018). There are several initiatives in the literature reported to decrease
negative health, social and societal effects of IV drug use such as overdose deaths,
financial burden for the individual and society and risks to the community of infectious
disease from needle stick injuries. In order to address these negative consequences,
addressing addiction is essential. There are several initiatives that have the potential to
decrease these consequences. These initiatives include rehabilitation programs,
medication assisted treatment, fentanyl test strips, naloxone training, decriminalization,
safe injection facilities, prison-based treatment programs, and NEPs.

Rehabilitation programs
There are a variety of rehabilitation programs which may range from weeks to
years. Some rehabilitation programs are faith based while others are not and are solely
focused on detox. In particular, one medication free residential rehabilitation program
found that out of the 100 participants, 47% left the treatment facility prematurely, 30%
were expelled and 18% successfully completed the program of either a 1 month stay or a
3-6 month stay (Darke, Williamson, Ross, & Teesson, 2006). Out of the 18% who
finished, 71% were not using heroin at the 1-month mark and 18% were not using heroin
for the duration of the follow up period (Darke, et. Al., 2006).
Faith based programs also offer a variety of options for the duration of treatment
and they can vary in program specifics. In addition to helping PWUID to cease their drug
use, faith-based treatment programs also have been reported to positively affect the
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individual’s life in other ways such as decreasing depression rates, improving self-esteem
and increasing physical activity levels (Lashley, 2018). Thus, this holistic approach to
treatment leads to positive effects on the individual’s well-being in addition to assisting
the individual to stop their drug use.
Another type of rehabilitation program combines a faith-based approach with
medication assisted treatment. This program incorporated mental health interventions in
combination with Islamic spiritual interventions in order to overcome their addiction
(Rashid, 2014). This program in particular used a Mosque as a space where individuals
struggling with IV drug use could go, obtain their methadone for free and be able to
participate in spiritual programs. Out of the total participants, 80% were actively
participating in both aspects of treatment at the 12-month point. These statistics are
actually better than the overall retention rates from non-spiritual methadone programs in
the area where the study took place (Rashid, 2014). In combination with an increased rate
of abstinence for IV drugs, participants reported significant improvements in overall
satisfaction with life, general health and social functioning (Rashid, 2014).

Medication assisted treatment
Replacement therapies, or opioid agonist therapies began in 1965, when two
researchers named Dole and Nyswander conducted a methadone replacement study on
individuals with chronic heroin use. They found that participants reported “craving relief,
a blockade of euphoria associated with subsequent heroin use, a Lazarus-type effect on
psychosocial functioning, with treated subjects resuming schooling, work and
relationships” (Wakeman, 2016). Medication assisted treatment is a long-term treatment
plan with methadone or buprenorphine as a replacement for heroin. Controversy exists
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regarding replacement therapies purporting that methadone or buprenorphine to combat
injection drug use is not a legitimate method of treatment because one drug is simply
being substituted for another drug. However, the World Health Organization recognizes
these mediations to be crucial, naming both methadone and buprenorphine to their list of
essential medications for the treatment of addiction (Frimpong, Shiu-Yee, & D’Aunno,
2017; Wakeman, 2016). It has been reported that 60-80% of individuals receiving
methadone or buprenorphine therapy, when dosed adequate, remain in treatment when
compared to traditional behavioral interventions. In a study looking at the duration of
methadone treatment in relation to continued heroin use, at the six month mark, 67% of
individuals continued to use heroin, however, out of individuals who continued to receive
methadone treatment for 4.5 years, only 8% continued to use heroin; thus depicting how
methadone treatment success increases with duration of time treated (Wakeman, 2016).
In a twelve-year study examining buprenorphine as opioid agonist treatment, the findings
were similar to the statistics reported from using methadone. When buprenorphine is used
long term to aid the individual in maintaining their abstinence from injection drug use,
individuals report a greater quality of life decreased opioid use and decreased
hospitalizations and emergency department visits (Weinstein, et. al, 2016). When
individuals were prescribed and followed the proper dosage of buprenorphine for greater
than one year, they were significantly less likely to cease use and relapse to injecting
heroin versus those individuals who had been treated for less than a year (Weinstein, et.
al., 2016). There was also a correlation with increased adherence to the program with
females, individuals with psychiatric diagnoses and individuals of older age. One reason
for a higher rate of compliance among females may be the ease of access to clinics being
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preferred over a long-term treatment facility program if the woman has children.
However, the reason for individuals with psychiatric diagnoses having higher rates of
compliance is intriguing and warrants further examination (Weinstein, et. al., 2016).
Medication assisted treatment (MAT) programs lessen the financial impact
hospitals and other healthcare organizations often are faced with when caring for
PWUID. In fact, these programs decrease healthcare costs 50%-62% because as a result
of treatment, the individual is less likely to need outpatient, inpatient or emergency
department services. Additionally, for example, it is estimated by treating 10% of
currently untreated individuals in New England with MAT, it would generate “550
million regional societal savings” (Wakeman, 2016). This monetary savings would
positively and definitively impact the community as a whole (Weinstein, et. al., 2016).
Medication assisted treatment has also been reported to decrease the incidence of
overdoses. After the introduction of methadone and buprenorphine therapy as a
treatment option, there was a steady decline in the number of overdose deaths (Schwartz,
et. al, 2013). In a 12-year study is was reported that deaths from overdose were reduced
for PWUID who received methadone and buprenorphine therapy as this was associated
with successful recovery from heroin addiction (Wakeman, 2016).

Fentanyl test strips
Fentanyl is fifty times more potent of a drug than heroin. Recently, it has been
reported than some heroin supply has been laced with fentanyl, making overdose more
prevalent because the individual does not know there is fentanyl in their heroin (Dowell,
Noonan, & Houry, 2017). Test strips that can let an individual know if there is any trace
of fentanyl in their heroin and is extremely beneficial in decreasing the number of
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overdose deaths from injection drug use with fentanyl laced heroin. NEPs often times
have fentanyl test strips available to their clients (HEAL, 2018).

Naloxone
Another way to combat heroin overdoses is with a drug called naloxone
(Narcan®). Naloxone is an opioid antagonist that reverses heroin and fentanyl induced
respiratory depression. Traditionally, Naloxone was solely used in the hospital setting to
revive someone who overdosed or if someone received too much pain medication.
Making naloxone available outside the hospital setting where overdose from heroin is
more likely to occur could potentially prevent mortality from a drug overdose (Strang,
2015). The concept is similar to the use of epinephrine (EpiPen) for anaphylaxis.
Epinephrine once primarily available only in the hospital setting for treatment of
anaphylaxis was made available to individuals who had a history of anaphylaxis when
exposed to certain antigens. Access to epinephrine outside of the hospital setting
significantly decreased anaphylaxis related mortality just as Narcan availability in the
community significantly reduces opioid related mortality (Strang, 2015). Access to
naloxone and administration training is often available through NEPs and they offer
PWUID the opportunity to become trained in naloxone administration. It has been
reported that 80% of PWUID use in the company of others, which makes training
PWUID to be able to administer naloxone to others reasonable and worthwhile (Strang,
2015). In a study in which 3,500 ten dose vials of naloxone were distributed to trained
PWUID there were 319 peer reversals with only one unsuccessful event (Maxwell et al.,
2006).
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Prison-based MAT treatment.
In addition, another way to reduce overdose deaths is by implementing prisonbased treatment. Unfortunately, 56-90% of PWUID go to prison at some point in their
lives. While in prison many individuals often times do not have the ability to continue to
use heroin so they are forced into cold turkey detoxification. This process significantly
decreases their tolerance to the drug as they are unable to use the drug for an extensive
amount of time while in jail. Consequently, when the individual is released from prison,
their tolerance is very low which places them in a very susceptible position for
overdosing when released from prison. This is because if they use the same amount of the
drug that they would typically use prior to being in prison, their body is no longer use to
it, making the risk of overdose very high (Crowley, & Van Hout, 2017). The risk of
relapsing is often high in individuals getting out of prison since they are usually then
faced with the triggers and situations in which they used in before (Crowley, & Van
Hout, 2017).
One method of combating heroin deaths after prison release is through the
implementation of medication assisted therapy (MAT) opioid substitution treatment
(OST) for opioid dependent inmates. The United States does not have many programs
OST programs. In Australia OST are available. It was reported that between 2000 and
2012 researchers tracked post release mortality of 16, 453 inmates enrolled in OST. They
found that when individuals completely adhered to their OST, the crude mortality rate
(CMR) within the first week was 10.9 per 1000 individual’s verses 59.5 per 1000
individuals (Degenhardt, et. al., 2014). The CMR pattern followed a similar pattern in
weeks 2-4 of post release inmates as well. Overall, treating inmates with opioid
dependence with OST in this prison in Australia using a multifactorial model resulted in
17

an 83% less risk of mortality following release from prison (Degenhardt, et. al., 2014).
Therefore, MAT programs, whether they are used in the community or in prisons, are one
method of reducing overdose death in PWUID.

Safe injection facilities
Safe injection facilities (SIF) or supervised consumption services allow an
individual to use IV drugs they have obtained elsewhere, in a safe, legal and controlled
facility with trained professionals around. These trained professionals are present if
someone overdoses and needs naloxone and provide sterile supplies which includes
syringes, needles, cookers, alcohol wipes, cotton, and tourniquets (We are the drug policy
alliance, 2018). SIF allows for proper disposal of used needles which then has the ability
to reduce the number of needles on the street. In a study at the first SIF in North America
in Vancouver established in 2003, individuals who utilize these sites were more likely to
self-initiation addiction services which then is positively correlated with cessation of IV
drug use (Vearrier, 2018), (Debeck, et. al., 2011). Out of the randomly selected
participants, 57% of participants were enrolled in addiction treatment. Overall, even
though SIF programs do not require initiation of addiction treatment, they promote harm
reduction by facilitating a safe environment with clean supplies. By accessing these
services, it has the ability to open the door for to PWUID to begin to seek treatment
services (Debeck et. al., 2011). Some cities in the US are now examining ways to
implement SIF, however, such initiatives are meeting resistance from neighbors who do
not want a facility like this in their neighborhood. Despite the impending difficulties,
thirteen cities are looking for ways to have SIFs available to their citizens (Allen, 2018).
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These facilities also can decrease the amount of injection equipment that is left in
public places because of the incentives that these facilities offer for bringing in used
needles in exchange for clean ones (Debeck, et. al., 2011). SIF are safe and monitored
and in addition to decreasing incidences of SSTIs from providing sterile equipment, they
also have nurses at the facility who are able to intervene if there is a critical situation
(Vearrier, 2018). SIF help foster therapeutic relationship between nurses who work at SIF
and the PWUID. This relationship can positively impact how the PWUID sees healthcare
professionals as well as decreasing the rates of hospitalizations because of the frequency
in which the nurses can assess the overall health of the clients of the SIF (Vearrier, 2018).

Decriminalization
Implementing the decriminalization associated with injection drug use has the
ability to positively impact PWUID. Currently, there are felony convictions for drug use
and possession charges. As a result, PWUID who were charged with a felony have
immense difficulty finding jobs, finding housing and obtaining professional licenses
(Vearrier, 2018). In addition, a felony charge can also affect having custody of children,
having a driver’s license and loss of state and/or federal assistance for education.
Decriminalizing certain possession charges to a misdemeanor has the potential to greatly
impact PWUID and could help them in many aspects (Vearrier, 2018).
Decriminalization of possession charges also decreases societal costs in terms of
court and prison costs. Drug related charges play a substantial role in the current “mass
incarceration” trend, thus by decreasing the amount of felony charges this would greatly
reduce costs associated with drug enforcement measures (Vearrier, 2018).
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The Law Enforcement Assisted Diversion (LEAD) program that the NEP in
Bangor (HEAL) has initiated aims at doing just this. Rather than arresting and charging
someone for a minor possession charge, police officers in Bangor who are trained in the
LEAD program are able to refer the individual to HEAL. The goals of this program are to
supply help to the individual if that is what the individual wishes (HEAL, 2018).

Needle exchange programs
Needle exchange programs (NEP’s) can decrease health consequences associated
with infection from injectable drugs for PWUID. Needle exchange programs are aimed
at decreasing the transmission of HIV, Hepatitis B, Hepatitis C and other blood borne
infections (Sawangjit, Khan, & Chaiyakunapruk, 2016). It has been reported expanding
NEP’s is the gateway to decreasing HIV rates in the US (Kulikowski & Linder, 2018).
Because PWUID who utilize a NEP are five times more likely to enter a treatment
program, these exchanges correlate with decreasing HIV and Hepatitis C infection rates
as well as overall cessation of heroin use (Kulikowski & Linder, 2018). In Europe, in 29
cities which had NEP programs, HIV rates decreased by 5.8% per year while the 52 cities
without NEPs, HIV rates increased by 5.9% (Wilson, Donald, Shattock, Wilson, &
Fraser-Hurt, 2015).
NEP’s are intended for PWUID who access the service however, if a PWUID is
unable to go to the exchange or is not ready to, they may still benefit from the NEP.
Some PWUID operate a secondary exchange for their peers and collect their friend's
needles to be swapped for sterile ones. A NEP in Baltimore, Maryland described how the
NEP aids even more people than just their clients that walk through their door because
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the NEP clients often times collect many people’s used needles and then redistribute the
clean needles they obtain from the NEP (Voytek, Sherman & Junge, 2003).
NEPs also improve the safety of the community by getting used needles off the
streets. Because these programs are run by collecting used needles in exchange for sterile
ones, it encourages PWUID to turn in their used needles rather than leaving them
somewhere in the community (Kulikowski & Linder, 2018). Overall, the needle
exchange programs work by reducing the time the needles and syringes are in circulation
in the community and therefore reduce the risk of the public coming in contact with dirty
needles. According to the North American Syringe Network, in the U.S. there are an
estimated 200 needle exchanges in thirty-three states (Ackerman, 2016). Michael
Botticelli, Director of the Office of National Drug Control Policy, states that not only do
these services reduce rates of infection, but they also provide a “transition into treatment
for people in the community” (Ackerman, 2016). The programs often also offer sex
education and prevention materials, referrals to medical care, legal and social services,
and drug treatment referrals (Alcabes, Drucker, Lurie & Wodakt, 1998).
In theory, because NEPs work to decrease infection rates in PWUID, this trend
has the potential to overall decrease the infection burden in all individuals regardless of
injection drug use history because there will be less people that have these bloodborne
infections in general. Similar to herd immunity with immunizations, if more and more
people are taking precautions against blood borne infections, this puts the general
community at a less risk of becoming infected as well (Sawangjit, Khan, &
Chaiyakunapruk, 2016).

21

Lastly, NEPs are cited as one of the least costly harm reduction methods, costing
an average of $23-71 dollars per person per year (Wilson, et. al., 2015). In fact, NEPs are
said to be “one of the most cost-effective public health interventions ever funded”
(Wilson, et. al., 2015).
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NEEDLE EXCHANGE PROGRAMS IN MAINE

There are five counties in Maine that offer needle exchange services; these
include (1) Portland Needle Exchange in Cumberland County, (2) Health Reach Harm
Reduction in Augusta, in Kennebec County, and (3) the Down East AIDS Network/
Health Equity Alliance (HEAL) with locations in Ellsworth, Bangor and Machias in
Hancock, Penobscot and Washington County (CDC, n.d.).
Specifically, the focus of this thesis is the Bangor Down East AIDS Network/
Health Equity Alliance (HEAL) and will explore perceptions and knowledge of nurse
who work in the emergency department regarding NEPs. Perceptions and knowledge of
emergency room nurses regarding NEP can impact utilization by clients. In Bangor,
HEAL offers syringe exchange, free Narcan administration training, a free health clinic,
case management, Law Enforcement Assisted Diversion, a food pantry and LGBTQ
services (Health Equity Alliance, 2018). However, the Health Equity Alliance syringe
exchange program continues to be underutilized in Bangor, Maine (T. McGuire, October
9, 2018).
Background
Needle exchange programs have been found to be effective at reducing
needlestick injuries and improving the health of PWUID (Jezek & Weedle, 2018). It is
reported that there are misconceptions and resistance to needle exchange programs
among the lay public, health care workers and police officers (Beletsky, et al., 2015). In
comparison to other developed countries, the United States uses syringe exchange
programs far less than Australia, Canada and various European countries ((Kulikowski &
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Linder, 2018). There are many reported social and political forces that may influence the
success of these programs. Opposition to needle exchange programs (NEP) includes the
thought that these programs enable drug use and perpetuate the existing problem. In
contrast, NEP’s have been found to actually reduce drug usage because clients who
utilize NEP services are five times more likely to enter treatment programs (Kulikowski
& Linder, 2018).
In terms of funding, from 1988-2015, there was no federal funding towards NEPs.
The state and local government was in charge of providing the totality of resources
needed to operate NEPs (Showater, 2018). It was not until 2016 that the United States
Congress passed legislation that supported federal funding. Consequently, states can now
get funding for costs related to running NEPs such as salaries and counseling, just not the
actual needles (Mcleaver, 2016). States and local government funding are still needed to
obtain the clean needles; however, the addition of federal funds means that many small
exchanges have the potential to provide additional services with the added funding
(Mcleaver, 2016).
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THE STUDY

In order to address how NEPs can be better utilized, it is important to identify
who is on the front lines interacting with PWUID. Of all health care providers,
emergency department (ED) nurses are most likely to come in contact with IV drug users
and have the opportunity to provide resources and compassionate care to individuals
struggling with injection drug addiction (Kulikowski & Linder, 2018). It has been
reported that if the PWUID senses a lack of compassion on the part of the healthcare
professional when seeking care, they may avoid seeking care in the future. Consequently,
this may result in a missed chance for education and referral to treatment (Bartlett,
Brown, Shattell, Wright, & Lewallen, 2013). Thus, if nurses can be educated on the
benefits of harm reduction services provided through NEP’s, they may be more likely to
make a referral.
Emergency department nurses are uniquely positioned to inform IV drug users of
the availability and benefits of needle exchange programs. Further, they are prime
candidates to advocate for creation of needle exchange programs in their community if
they are not available. Thus, it would be insightful to understand the beliefs, values and
perceptions of ER nurses in regard to need exchange programs in Bangor. The purpose if
this study is to describe the perceptions of emergency room nurses of the barriers
regarding the full utilization of needle exchange programs in Bangor, Maine.
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Methods
This study is a non-experimental descriptive design. An anonymous survey to
determine perceptions of needle exchange facilities were distributed to emergency room
nurses in Bangor, Maine at St. Joseph's Hospital (Appendix C). Participants were invited
to participate in an interview in addition to completing the survey. Those nurses who
wish to participate in the interview were asked to provide their contact information on the
consent form by printing their name and contact information (Appendix B). This study
was approved by the University of Maine IRB.
Results
The 75 nurses employed at this ED in Bangor, ME were given the opportunity to
participate in the survey. Nine surveys were returned and the results were examined. The
amount of nurses surveyed was 12% of the amount of ED nurses employed at this
hospital. Out of the nurses’ surveys, 88% of them reported that they interact with PWUID
daily. Three (33%) of nurses who completed the survey nurses that said they had heard of
HEAL. Only one out of the nine (10%) nurses surveyed reported actually making a
patient referral to HEAL. Thirty-three percent of nurses surveyed felt that needle
exchange programs have the ability to reduce the rate of infectious diseases in PWUID
and in community members. Study participants were provided the opportunity to write
comments on the survey. Four participants commented on the survey. Comments
included voiced that resources in Bangor are limited, that the individual must want
treatment in order for a referral to a detox program to be made, and that they do not see a
lot of success with treatment other than the occasional referral and administering Narcan
which is not considered long term treatment. One nurse commented that PWUID need
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someone who can provide them with compassionate care and empathy, will not judge
them and will support their medical needs and decisions at the time they are seeking
treatment.
Discussion
Overall, the results from this survey indicate there may be a lack of awareness of
NEP programs among nurses who have the ability to promote their utilization.
Furthermore, in order to increase the utilization of NEP programs, educational sessions
for frontline medical professionals could be implemented. If nurses are not aware of
HEAL (the NEP in Bangor) utilization of this program will likely be diminished. When
nurses in the emergency department establish a rapport with PWUID and are aware of the
full range of NEP services, they can communicate this to PWUID. They can also provide
PWUID with accurate information on how to access theses services.
Increased utilization of HEP could be facilitated if nurses who are aware of these
services communicate this to their nursing colleagues as well as other healthcare
providers. Additionally, other ways to increase the utilization of NEP programs could be
further advertising in public places, posters in hospital ED waiting rooms in addition to
increasing the amount of people who know about what they are and what they can do
overall.
Education of ED and floor nurses specific to NEP programs and benefits could
also be useful in order to implement hospital wide knowledge of local services offered in
the greater Bangor area. Hospitals and walk-in-care places could implement mandatory
trainings in which employees are trained in multiple aspects of caring for PWUID and
offering referral options when appropriate. If more professionals are aware of the benefits
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of NEP services, utilization may be increased. Additionally, a pamphlet that lists all of
the services for PWUID in the Bangor area such as methadone or suboxone clinics, detox
programs, where to obtain Narcan training and kits, and NEP locations may increase
utilization of these services. Although such a list may be available online, many PWUID
may not have access to a computer particularly if they have unstable housing. Increasing
awareness for all healthcare professionals of services for PWUID could create a more
streamlined process where every patient would have an equal chance to obtain services.
Limitations of the research include a small sample size because out of the 75
employed ED nurses, 9 surveys were collected, which comprises 12% of the total amount
of nurses in the ED in this study. Future research is needed to encompass a larger sample
size in order to draw in more data. This study could be replicated on a larger scale to
further examine the prevalence of knowledge regarding local NEP services.
Conclusion
Needle exchange programs have been found to be effective at reducing
needlestick injuries and improving the health of PWUID (Jezek & Weedle, 2018).
Results of this study suggest that many nurses who work in the emergency department
are unaware of the existence and scope of services of the NEP located in Bangor.
Additionally, many nurses do not recognize the potential that NEPs have of reducing
harm for PWUID such as decreasing infection and overdose rates and increasing the
likelihood of entering treatment programs. Further research is needed to examine how the
underutilization of NEPs could be addressed. A starting point may be to begin
mandatory hospital personnel education particularly emphasizing the role of ED nurses
regarding this topic since 88% of ED nurses who participated in this study reported that
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they interact with PWUID daily while at work. NEPs have the potential to significantly
decrease the number of needles in public places, decrease infection rates in PWUID as
well as in community members, and are the gateway to further treatment. Examination of
the perceptions of ED nurses who participated in this study gives rise to opportunities to
engage nurses in supporting programs that address the opioid epidemic in the Bangor
area as well as in the state of Maine.
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Appendix A

Presentation Script Regarding the Nature of the Study
Hello. My name is Theresa Murray and I am a senior nursing student in the honors
program at the University of Maine. Mary Tedesco-Schneck Ph.D., RN. CPNP is my
faculty sponsor and supervising this study.

I have been researching the impact of needle exchange programs for persons who use IV
drugs on the health of the individual as well as the local community. I am seeking to
more fully understand:
Interactions between emergency room nurses and persons who use IV drugs.
Perceptions of emergency room nurses regarding programs for persons who use IV
drugs.

If you would like to participate in the anonymous survey I am asking you to please fill it
now. This anonymous survey should take between 5-10 minutes to complete. If you
would also like to participate in the short interview (approximately 30 minutes), please
print your name on the consent form with contact information.

I will contact you and arrange for a mutually agreed upon time to conduct the interview.
The interview can be conducted in a private room in the St. Joseph’s Healthcare
Emergency Department or the office of Mary Tedesco-Schneck at the University of
Maine, Dunn Hall, Room 218, Orono, Maine. I will conduct the interviews but they will
not be recorded. Themes from the conversation will be jotted down in a notebook. The
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notebook will also be kept in a locked filing cabinet in the office of Mary TedescoSchneck until May 16, 2019. On May 16, 2019 all surveys, consents, and notebook
entries will be shredded.
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Appendix B

Consent for Survey Regarding Needle Exchange Programs and the Law Enforcement
Assisted Diversion Program
You are invited to participate in a research project being conducted by Theresa Murray,
an undergraduate nursing student at the University of Maine in the School of
Nursing. Mary Tedesco-Schneck Ph.D., RN, CPNP is the faculty sponsor from the
University of Maine in the School of Nursing. The purpose of the research is to
understand the perceptions of emergency room nurses regarding needle exchange
programs in Bangor, Maine. You must be at least 18 years of age to participate.

What Will You Be Asked to Do?
If you decide to participate, you will be asked to complete an anonymous survey
that will not have any personal identifiers. It should take you about 5-10 minutes to
complete the survey. Please keep the consent form. After completing, please put your
survey in envelope #1.
If you are willing to participate in the short interview (approximately 30 minutes):
You will need to write down your contact information on the end of the consent form,
tear it off, and put it in envelope #2. During the interview you will be asked to comment
further on the questions that are included on the survey. The interview will be conducted
in a private room in the St. Joseph’s Healthcare Emergency Department or the office of
Mary Tedesco-Schneck at the University of Maine, Dunn Hall, Room 218, Orono,
Maine. The principal investigator (Theresa Murray) will conduct the interviews but they
will not be recorded. Identifiers of the interviewee will not be recorded only themes from
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the conversation will be jotted down in a notebook. We would let you know of the time
and place of the interview within 1-2 weeks following collection of your survey.

Risks
The risks to completing this survey are your time and possible inconvenience.
You may skip any questions that you do not wish to answer.

Benefits
While this study will have no direct benefit to you, this research may help us learn
more about the perceptions of emergency room nurses regarding needle exchange
programs in Bangor, Maine. This can help us understand how Needle Exchange
Programs can be better utilized and if there are additional resources for persons that use
injectable drugs and the community that should be considered.
As a result of this research additional resources suggested by participants may be
implemented in the future.

Confidentiality
There will be no identifiers on the survey or interview notes linking you to the
data. The signed consents, surveys and notebook will be kept in a locked filing cabinet in
the office of Mary Tedesco-Schneck until May 16, 2019. On May 16, 2019 all surveys,
consents, and notebook entries will be shredded.
Please do not write your name on the survey, for they are anonymous. However, due to
the nature of an interview, if you chose to be interviewed, they would be confidential.
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Voluntary
Participation is voluntary. If you choose to take part in this study, you may stop
at any time. You may skip any questions you do not wish to answer.

Contact Information
If you have any questions about this study, please contact me (Theresa Murray) at
theresa.murray@maine.edu . You may also reach the faculty advisor (Mary TedescoSchneck) on this study at 207-581-3427 or mary.tedescoschneck@maine.edu . If you
have any questions about your rights as a research participant, please contact the Office
of Research Compliance, University of Maine, 207/581-2657 (or e-mail
umric@maine.edu ).
Please keep this consent form

(Tear off below information and give to Theresa Murray if you would be willing to
participate in an interview)

For participants who would be willing to participate in an interview:
I will contact you in 1-2 weeks to schedule and interview time.
Please provide contact information
here: __________________________________________________________
________________________________________
Printed Name of Participan
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Appendix C
Anonymous Survey
Please rate how frequently you interact with persons who use IV drugs when you are on
duty by circling one of the following responses.
About once a
month

About twice a
month

About once a
week

More than once a
week

Daily

Please choose any interventions you implement when working with persons who use IV
drugs. You may circle more than one option.
Referral to health services
Referral to treatment
programs
Other:

Referral to needle exchange
program.
Referral to social services.
I do not implement any
interventions.

Please describe the impact you believe your interventions have on persons who use IV
drugs.

Do you feel that needle exchange programs help to reduce that rate of infectious diseases
among persons who use IV drugs?

____ Yes
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___ No

Do you feel that needle exchange programs help to reduce that rate of infectious diseases
among community members who may be exposed to used needles?

____ Yes

___ No

Please circle one of the following choices in regards to person who use IV drugs and the
Health Equity Alliance (HEAL)
I have never heard of HEAL.
I have heard of HEAL but have never made a
referral.
I have heard of HEAL and have made a referral.

Please feel free to share any other comments regarding needle exchange programs and/or
your interventions with persons who use IV drugs.

Please circle one of the following choices in regards to person who use IV drugs and the
Law Enforcement Assisted Diversion (LEAD) program
I have never heard of LEAD.
I have heard of LEAD but have never made a
referral.
I have heard of LEAD and have made a referral.
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Thank you for your time and for sharing your thoughts.

Theresa Murray
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Appendix D

Interview Script

Thank you for providing me with the opportunity to interview you regarding
perceptions of nursing interventions and programs for person who use injection drugs.
The purpose if this study is to describe the perceptions of emergency room nurses
regarding needle exchange programs in Bangor, Maine. This information may facilitate
understanding of how Needle Exchange Programs can be better utilized and if there are
additional resources for persons that use injectable drugs and the community that should
be considered.
There are no identifiers linking you to the data from this interview. The interview
is not recorded; only themes from the conversation will be jotted down in a notebook.
Therefore, this interview is confidential.

The notebook will be kept in a locked filing cabinet in the office of Mary TedescoSchneck until May 16, 2019. On May 16, 2019 all surveys, consents, and notebook
entries will be shredded.
1. Do you have any questions before we begin?
2. Can you share with me the interventions you choose to implement when working
with persons who use injectable drugs?
3. What impact do you believe your interventions have on persons who use IV
drugs?
4. What are your thoughts about needle exchange programs?
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5. What are your thoughts about the Health Equity Alliance (HEAL) program?
6. What are your thoughts about the Law Enforcement Assisted Diversion (LEAD)
program?
7. Are there any other thoughts regarding your perceptions of nursing interventions
and programs for person who use injection drugs?

Thank you for time and sharing your thoughts.
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